Mutations in CHEK2 Associated with Prostate Cancer Risk
The American Journal of Human Genetics2003Vol. 72(2), pp. 270–280
Citations Over TimeTop 1% of 2003 papers
Xiangyang Dong, Liang Wang, Ken Taniguchi, Xianshu Wang, Julie M. Cunningham, Shannon K. McDonnell, Chiping Qian, Angela F. Marks, Susan L. Slager, Brett J. Peterson, Jeremy C. Smith, John C. Cheville, Michael L. Blute, Steven J. Jacobsen, Daniel J. Schaid, Donald J. Tindall, Stephen N. Thibodeau, Wanguo Liu
Related Papers
- → Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers(2021)28 cited
- → A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility Genes(2022)24 cited
- → Spectrum and frequency of CHEK2 variants in breast cancer affected and general population in the Baltic states region, initial results and literature review(2022)12 cited
- → Frequency and spectrum of CHEK2 variants in a large Brazilian set of germline-tested patients.(2023)2 cited
- [CHEK2 and breast cancer risk].(2002)